Evidence map›Paper›PMID 26681907›Full record

ArticleP & T : a peer-reviewed journal for formulary management2015

Effect of Intravenous Acetaminophen on Postoperative Opioid Use in Bariatric Surgery Patients.

Shan Wang, Ronik Saha, Neal Shah, Adel Hanna, Jonas DeMuro, Rose Calixte, Collin Brathwaite

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in P & T : a peer-reviewed journal for formulary management, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03198871 (Role of Scheduled Intravenous Acetaminophen for Postoperative Pain Management in an Enhanced Recovery After Surgery), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03198871 phase4completednot on this mapstarted 2018, after this paper: background citation

Role of Scheduled Intravenous Acetaminophen for Postoperative Pain Management in an Enhanced Recovery After Surgery (ERAS) Population: A Prospective, Randomized, Double-Blind and Placebo-Controlled Clinical Trial

TypeinterventionalSponsorKathirvel SubramaniamRan2018 to 2020Enrolled180ConditionsAbdominal Wall Hernia, Pancreatic Diseases, Bowel Disease, Gastric DiseaseArmsAcetaminophen Injectable Product, Sodium Chloride 0.9%, Intravenous
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Improvement in Functional Outcomes After Elective Symptomatic Orthopaedic Implant Removal.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2020
    Article
  7. Article
  8. Article
  9. Intravenous Acetaminophen -an Ineffective Analgesic?P & T : a peer-reviewed journal for formulary management · 2016
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Shan Wang
Ronik Saha
Neal Shah
Adel Hanna
Jonas DeMuro
Rose Calixte
Collin Brathwaite

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of opioids to achieve adequate pain relief following surgery is a common clinical practice. Opioids, however, are associated with serious adverse effects, such as respiratory depression, excessive sedation, and prolonged ileus, as well as increased mortality. The administration of intravenous (IV) acetaminophen to control postoperative pain has been effective in reducing opioid consumption in various surgical populations, but no studies have been conducted in bariatric surgery patients. This investigation was performed to determine whether IV acetaminophen reduces opioid requirements after bariatric surgery.

methodsIV acetaminophen was added to the Winthrop-University Hospital formulary in September 2012. We conducted a retrospective chart-review analysis of bariatric surgery patients who received at least four doses of IV acetaminophen (1 g every six hours) plus opioids from October 2012 to March 2013 (after IV acetaminophen was added to the hospital formulary), compared with bariatric surgery patients who received only opioids for postoperative pain control from January 2012 to June 2012 (before IV acetaminophen was added to the hospital formulary). The study's primary endpoint was the difference between the two groups in opioid consumption, expressed in oral morphine equivalents (OMEs). Secondary endpoints included the reduction in the baseline pain score; the total amount of each opioid used; and the average hospital length of stay (LOS).

resultsA total of 96 patients were identified for potential enrollment from January 2012 to March 2013. Eight patients, however, did not qualify for participation because they had received only one dose of IV acetaminophen. The remaining 88 patients comprised two study groups: IV acetaminophen plus opiates (n = 44) and IV opiates alone (n = 44). Paradoxically, the patients in the acetaminophen/opiates group required significantly more opiates (in OMEs) compared with the group that received opiates alone (median, 93.5 mg versus 63.0 mg, respectively; P = 0.017). There were no significant differences between the two treatment groups in terms of the median change from baseline in pain scores (-4 versus -4; P = 0.162) or the median hospital LOS (two days versus two days; P = 0.704).

conclusionIV acetaminophen did not reduce opioid use for postoperative pain management in bariatric surgery patients.

Indexed as

bariatric surgeryintravenous acetaminophenopioidspostoperative pain

Identifiers

PMID26681907
PMCPMC4671470
OpenAlexW2413646312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.